GlassScriptPhysician profile
Mark Anthony Thimineur
NPI 1336180314
$16,813.23
in general payments reported to CMS, 2019-2025
45 companies · $1,925 in 2025
The $1,925 reported for 2025 was more than what 78% of Interventional Pain Medicine providers received nationally (typical 2025 total: $676).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $5,409 · 2020: $1,222 · 2021: $2,031 · 2022: $2,071 · 2023: $2,060 · 2024: $2,095 · 2025: $1,925.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $6,080.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $6,080.09 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbott Laboratories | $5,386.59 | 2019-2025 | Proclaim, Eterna |
| Saluda Medical Americas, INC. | $1,691.93 | 2022-2025 | Evoke, Evoke Scs |
| Collegium Pharmaceutical, INC. | $1,237.61 | 2019-2025 | Belbuca, Xtampza |
| Boston Scientific Corporation | $1,207.84 | 2019-2023 | |
| Biotronik Nro, INC. | $1,108.19 | 2023-2025 | Prospera, Biotronik |
| Abbvie INC. | $1,054.44 | 2021-2025 | Qulipta, Ubrelvy |
| Spr Therapeutics, INC | $595.71 | 2024-2025 | Sprint Pns System |
| Pfizer INC. | $547.96 | 2020-2025 | |
| Painteq LLC | $467.48 | 2021-2024 | Painteq |
| Vertos Medical, INC. | $379.54 | 2022-2024 | Mild Device Kit |
| Scilex Pharmaceuticals INC. | $361.25 | 2019-2024 | Ztlido |
| Teva Pharmaceuticals USA, INC. | $293.90 | 2019-2025 | Austedo Xr, Ajovy |
| Avanir Pharmaceuticals, INC. | $253.41 | 2021-2022 | |
| Medtronic, INC. | $250.76 | 2022-2025 | Intellis Adaptivestim, Accurian, Inceptiv |
| Amgen INC. | $187.10 | 2020-2022 |
Show all 45 companies
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Mark Thimineur listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.